Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bio-Rad Laboratories Inc.

    NYSE: BIO · Real-Time Price · USD
    231.74
    4.83 (2.13%)
    At close: Jun 16, 2025, 3:59 PM
    231.70
    -0.02%
    After-hours: Jun 16, 2025, 06:00 PM EDT
    2.13%
    Bid 225.25
    Market Cap 6.31B
    Revenue (ttm) 2.54B
    Net Income (ttm) -2.23B
    EPS (ttm) -76.54
    PE Ratio (ttm) -3.03
    Forward PE 24.04
    Analyst Buy
    Ask 238.15
    Volume 288,441
    Avg. Volume (20D) 386,185
    Open 228.23
    Previous Close 226.91
    Day's Range 222.88 - 232.61
    52-Week Range 211.43 - 387.99
    Beta 0.94

    About BIO

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BIO
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for BIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    -1.5%
    Bio-Rad Laboratories shares are trading higher aft... Unlock content with Pro Subscription
    4 months ago
    -1.92%
    Bio-Rad Laboratories shares are trading lower after the company missed Q4 revenue estimates.
    news image

    16 hours ago · businesswire.com

    Enveric Biosciences Announces Participation in 2025 BIO International Convention

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therap...

    news image

    3 days ago · accessnewswire.com

    Aptevo Participating in the BIO International Convention

    SEATTLE, WA / ACCESS Newswire / June 13, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its pro...

    news image

    5 days ago · businesswire.com

    Niagen Bioscience to Participate in the BIO 2025 International Convention

    LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the...

    news image

    1 week ago · accessnewswire.com

    Lexaria Attending BIO International Convention

    Biotechnology Sector's Premier Strategic Partnering Event KELOWNA, BC / ACCESS Newswire / June 5, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global inn...

    news image

    2 weeks ago · accessnewswire.com

    Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform

    Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human dosing in the first half of 2026 MIAMI, FL / ACCESS Newswire / June 2, 2025 /...

    news image

    2 weeks ago · businesswire.com

    Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference

    HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chie...

    news image

    1 month ago · zacks.com

    Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends

    Explore Bio-Rad's (BIO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

    news image

    1 month ago · businesswire.com

    Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

    HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executiv...

    news image

    1 month ago · businesswire.com

    KRONOS BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kronos Bio, Inc. - KRON

    NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ...

    news image

    1 month ago · zacks.com

    BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket

    Bio-Rad witnesses first-quarter top-line decline in its Life Science segment, primarily due to challenges in the academic research market.

    Add to Watchlist